Fig. 1
From: Splenic-targeting biomimetic nanovaccine for elevating protective immunity against virus infection
Characterization of MR-PLGA/OVA NVs. A Size and zeta potential of PLGA NVs, MR-PLGA/OVA NVs and CMR-PLGA/OVA NVs (n = 3). B Representative TEM images of PLGA NVs and MR-PLGA/OVA NVs. The scale bar represents 100 nm. C SDS-PAGE pattern of proteins from RBC membrane and MR-PLGA/OVA NVs. D The particle size of MR-PLGA/OVA NVs before and after lypophilization. E In vitro OVA release profile from MR-PLGA/OVA NVs (n = 3)